The Annual General Meeting of Pharmacists Corporation Limited (“YSB”) was held on 23 May 2024, and all proposals including audit of financial statements, election of directors and remuneration decisions were approved at the meeting. The Meeting approved the Audited Consolidated Financial Statements and the Board's Reports and Auditors' Reports for the year ended December 31, 2023, and re-elected Mr. Zhu Ziyang as a Non-Executive Director and Mr. Zhao Hongqiang as an Independent Non-Executive Director, while authorizing the Board to determine the remuneration of the Directors. In addition, the shareholders have renewed the corporate auditor of Delkin Accounting and granted the Board of Directors a general mandate to repurchase and issue shares. All resolutions received more than 67% of the votes in favor, with several receiving full votes in favor. The voting results of the Annual General Meeting showed that the board of directors of the drugmaker had broad shareholder support.

The Annual General Meeting of Pharmacists Corporation Limited (“YSB”) was held on 23 May 2024, and all proposals including audit of financial statements, election of directors and remuneration decisions were approved at the meeting. The Meeting approved the Audited Consolidated Financial Statements and the Board's Reports and Auditors' Reports for the year ended December 31, 2023, and re-elected Mr. Zhu Ziyang as a Non-Executive Director and Mr. Zhao Hongqiang as an Independent Non-Executive Director, while authorizing the Board to determine the remuneration of the Directors. In addition, the shareholders have renewed the corporate auditor of Delkin Accounting and granted the Board of Directors a general mandate to repurchase and issue shares. All resolutions received more than 67% of the votes in favor, with several receiving full votes in favor. The voting results of the Annual General Meeting showed that the board of directors of the drugmaker had broad shareholder support.